Coloplast A/S
Other OTCTotal Valuation
Coloplast A/S carries a market capitalization of 12.45B, placing it among publicly traded companies globally. Its enterprise value stands at 153.00B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.
| Market Cap | 12.45B |
| Enterprise Value | 153.00B |
Share Statistics
Coloplast A/S currently has 225.37M shares outstanding.
| Shares Outstanding | 225.37M |
| Owned by Insiders (%) | N/A |
| Owned by Institutions (%) | N/A |
Valuation Ratios
Coloplast A/S trades at a trailing price-to-earnings ratio of 31.78. The price-to-sales ratio is 4.65, and the price-to-book ratio stands at 7.60.
| PE Ratio | 31.78 |
| PS Ratio | 4.65 |
| PB Ratio | 7.60 |
| P/TBV Ratio | -9.62 |
| P/FCF Ratio | 16.38 |
| P/OCF Ratio | 20.15 |
Enterprise Valuation
On an enterprise value basis, Coloplast A/S trades at an EV/EBITDA multiple of 20.34 and an EV/FCF ratio of 17.59. The EV/Sales ratio of 5.49 reflects the premium investors are willing to pay for the company's revenue stream, while the EV/EBIT multiple of 20.34 provides insight into valuation relative to core operating earnings.
| EV / Sales | 5.49 |
| EV / EBITDA | 20.34 |
| EV / EBIT | 20.34 |
| EV / FCF | 17.59 |
Financial Position
Coloplast A/S maintains a current ratio of 1.00, meaning it holds 1.0x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 147.22, indicating elevated leverage, while an interest coverage ratio of 6.25 demonstrates adequate ability to service its debt obligations.
| Current Ratio | 1.00 |
| Quick Ratio | 0.07 |
| Debt / Equity | 147.22 |
| Debt / EBITDA | 3.22 |
| Interest Coverage | 6.25 |
Financial Efficiency
Coloplast A/S posts a return on equity of 23.36 and a return on invested capital of 11.68.
| Return on Equity (ROE) | 23.36 |
| Return on Assets (ROA) | 8.45 |
| Return on Invested Capital (ROIC) | 11.68 |
| Return on Capital Employed (ROCE) | 11.63 |
| Revenue Per Employee | N/A |
| Employee Count | N/A |
| Inventory Turnover | 2.43 |
Taxes
Over the trailing twelve months, Coloplast A/S has paid 2.13B in income taxes, reflecting an effective tax rate of 34.33.
| Income Tax | 2.13B |
| Effective Tax Rate | 34.33 |
Stock Price Statistics
Coloplast A/S's stock has declined approximately -33.68665% over the past 52 weeks. The 50-day moving average sits at 60.80, while the 200-day moving average is 77.07.
| Beta (5Y) | N/A |
| 52-Week Price Change | -33.68665% |
| 50-Day Moving Average | 60.80 |
| 200-Day Moving Average | 77.07 |
| Average Volume (20 Days) | N/A |
Income Statement
Over the trailing twelve months, Coloplast A/S generated 27.87B in revenue and converted that into 4.08B in net income, yielding earnings per share of 18.09. EBITDA reached 7.52B, while operating income came in at 7.52B.
| Revenue | 27.87B |
| Gross Profit | 18.82B |
| Operating Income | 7.52B |
| Pretax Income | 6.21B |
| Net Income | 4.08B |
| EBITDA | 7.52B |
| EBIT | 7.52B |
| Earnings Per Share (EPS) | 18.09 |
Balance Sheet
Coloplast A/S holds 726.00M in cash and equivalents against 24.22B in total debt, resulting in a net debt position of 22.52B. Total book value stands at 17.04B, with working capital of 3.00M providing operational flexibility.
| Cash & Cash Equivalents | 726.00M |
| Total Debt | 24.22B |
| Net Debt | 22.52B |
| Equity (Book Value) | 17.04B |
| Book Value Per Share | 75.65 |
| Working Capital | 3.00M |
Cash Flow
Coloplast A/S produced 6.43B in operating cash flow over the past twelve months. After subtracting -1.48B in capital expenditures, free cash flow totaled 4.95B - equivalent to 21.97 per share.
| Operating Cash Flow | 6.43B |
| Capital Expenditures | -1.48B |
| Free Cash Flow | 4.95B |
| FCF Per Share | 21.97 |
Margins
Coloplast A/S operates with a gross margin of 67.55, reflecting its pricing power and cost economics. The operating margin of 26.99 and net profit margin of 14.62 provide insight into operational efficiency.
| Gross Margin | 67.55 |
| Operating Margin | 26.99 |
| Pretax Margin | 22.27 |
| Profit Margin | 14.62 |
| EBITDA Margin | 26.99 |
Dividends & Yields
The company's payout ratio of 121.67 indicates the proportion of earnings distributed to shareholders.
| Dividend Per Share | 22.01 |
| Dividend Yield | N/A |
| Payout Ratio | 121.67 |
| Shareholder Yield | 4.05 |
| FCF Yield | 6.11 |
Stock Splits
Coloplast A/S's most recent stock split took place on December 18, 2012 with a 1:5 split ratio.
| Last Split Date | 12/18/2012 |
| Split Ratio | 1:5 |
Scores
Coloplast A/S posts an Altman Z-Score of 6.72, well above the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.
| Altman Z-Score | 6.72 |